Evangelo Boumis

Medicine & Life Sciences

1. HIV 100%
2. Highly Active Antiretroviral Therapy 47%
3. HIV-1 41%
4. Atazanavir Sulfate 36%
5. Lamivudine 34%
6. Ebola Hemorrhagic Fever 30%
7. Endocarditis 30%
8. Ritonavir 28%
9. Viremia 26%
10. Therapeutics 26%
11. Chronic Hepatitis 25%
12. Mutation 23%
13. Genotype 22%
14. Reverse Transcriptase Inhibitors 21%
15. Drug Resistance 21%
16. Viral Load 20%
17. Acquired Immunodeficiency Syndrome 17%
18. efavirenz 17%
19. Ribavirin 16%
20. Virus Shedding 16%
21. Virus Diseases 16%
22. SARS Virus 15%
23. Pharmaceutical Preparations 14%
24. Pulmonary Hypertension 14%
25. Italy 14%
26. Bacterial Pneumonia 14%
27. Hepacivirus 13%
28. HIV Infections 13%
29. Interferons 13%
30. Interferon-alpha 13%
31. Human immunodeficiency virus 1 reverse transcriptase 12%
32. Chronic Hepatitis D 12%
33. favipiravir 12%
34. Opportunistic Infections 12%
35. Enfuvirtide 11%
36. Ebolavirus 11%
37. Tenofovir 11%
38. Subacute Thyroiditis 11%
39. peginterferon alfa-2a 11%
40. Infections 11%
41. Viral Pneumonia 11%
42. Yersinia pseudotuberculosis 11%
43. Keratoconjunctivitis Sicca 11%
44. Viral RNA 10%
45. Guidelines 10%
46. Hereditary Hemorrhagic Telangiectasia 10%
47. Hepatitis Delta Virus 10%
48. RNA 10%
49. Sierra Leone 10%
50. Salvage Therapy 9%